BIOPHARMA has made notable strides in early diagnosis, with instances including African Horse Sickness in 1990, West Nile fever in 1996, 2003, and 2010, Blue Tongue and Epizootic Haemorrhagic Disease of cattle in 2004 and 2006, and Peste des Petits Ruminants in 2008.

Through advanced techniques such as real-time PCR, BIOPHARMA has swiftly identified these infectious diseases, enabling health authorities to proactively implement measures to prevent their introduction and spread within the national territory.

Amidst the global crisis of avian influenza (bird flu) in 2005, BIOPHARMA played a pivotal role in national disease monitoring efforts. Leveraging real-time PCR and other techniques, the company ensured rapid diagnosis, facilitating preemptive measures by health authorities to forestall the introduction of avian influenza into the country.

BIOPHARMA’s prompt and precise diagnostic capabilities have been crucial in safeguarding public health and the poultry industry against the threat of avian influenza.

Furthermore, BIOPHARMA has made significant contributions to serological surveys, particularly in the analysis of exotic contagious diseases either introduced into Morocco or at risk of introduction. Diseases such as foot-and-mouth disease, African Horse Sickness, West Nile fever, peste des petits ruminants (ou Small Ruminant Pestilence), Camelpox, and Rift Valley Fever have been the focus of serological surveillance efforts, with BIOPHARMA’s expertise playing a vital role in disease detection, monitoring, and control strategies.

Through collaboration with veterinary health authorities, BIOPHARMA has enhanced Morocco’s capacity to combat animal diseases, protect livestock health, and safeguard public health interests.